Evidence map›Paper›PMID 29529044›Full record

ArticlePloS one2018

WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis.

Masafumi Kobayashi, Maiko Miyagawa, Shin-Ya Nishio, Hideaki Moteki, Taro Fujikawa, Kenji Ohyama, Hirofumi Sakaguchi, Ikuyo Miyanohara, Akiko Sugaya, Yasushi Naito and 11 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Comprehensive overview of disease models for Wolfram syndrome: toward effective treatments.Mammalian genome : official journal of the International Mammalian Genome Society · 2024
    Review
  10. Review
  11. Wfs1Cell death & disease · 2023
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. A Novel MissenseBioMed research international · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 13 institutions in 1 country.

Masafumi KobayashiDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.
Maiko MiyagawaDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.
Shin-Ya NishioDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.
Hideaki MotekiDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.
Taro FujikawaDepartment of Otolaryngology, Tokyo Medical and Dental University, Tokyo, Japan.
Kenji OhyamaDepartment of Otorhinolaryngology, Tohoku Rosai Hospital, Sendai, Japan.
Hirofumi SakaguchiDepartment of Otorhinolaryngology-Head and Neck Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Ikuyo MiyanoharaDepartment of Otolaryngology-Head and Neck Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Akiko SugayaDepartment of Otolaryngology-Head and Neck Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Yasushi NaitoDepartment of Otolaryngology, Kobe City Medical Center, Kobe, Japan.
Shin-Ya MoritaDepartment of Otolaryngology-Head and Neck Surgery, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
Yukihiko KandaKanda ENT Clinic, Nagasaki Bell Hearing Center, Nagasaki, Japan.
Masahiro TakahashiDepartment of Otorhinolaryngology-Head and Neck Surgery, Yokohama City University School of Medicine, Yokohama, Japan.
Kotaro IshikawaDepartment of Otolaryngology, National Rehabilitation Center for Persons with Disabilities, Tokorozawa, Saitama, Japan.
Yuki NaganoDepartment of Otolaryngology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Tetsuya TonoDepartment of Otolaryngology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
Chie OshikawaDepartment of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Chiharu KiharaDepartment of Otolaryngology-Head and Neck Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Haruo TakahashiDepartment of Otolaryngology-Head and Neck Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Yoshihiro NoguchiDepartment of Hearing Implant Sciences, Shinshu University School of Medicine, Matsumoto, Japan.
Shin-Ichi UsamiDepartment of Otorhinolaryngology, Shinshu University School of Medicine, Matsumoto, Japan.ORCID 0000-0002-5068-6122
Shinshu University · JPNagasaki University · JPUniversity of Miyazaki · JPHokkaido University · JPKagoshima University · JPKobe City Nishi-Kobe Medical Center · JPKyoto Prefectural University of Medicine · JPKyushu University · JPNational Rehabilitation Center for Persons with Disabilities · JPOkayama University · JPTohoku Rosai Hospital · JPTokyo Medical and Dental University · JPYokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A heterozygous mutation in the Wolfram syndrome type 1 gene (WFS1) causes autosomal dominant nonsyndromic hereditary hearing loss, DFNA6/14/38, or Wolfram-like syndrome. To date, more than 40 different mutations have been reported to be responsible for DFNA6/14/38. In the present study, WFS1 variants were screened in a large series of Japanese hearing loss (HL) patients to clarify the prevalence and clinical characteristics of DFNA6/14/38 and Wolfram-like syndrome. Massively parallel DNA sequencing of 68 target genes was performed in 2,549 unrelated Japanese HL patients to identify genomic variations responsible for HL. The detailed clinical features in patients with WFS1 variants were collected from medical charts and analyzed. We successfully identified 13 WFS1 variants in 19 probands: eight of the 13 variants were previously reported mutations, including three mutations (p.A684V, p.K836N, and p.E864K) known to cause Wolfram-like syndrome, and five were novel mutations. Variants were detected in 15 probands (2.5%) in 602 families with presumably autosomal dominant or mitochondrial HL, and in four probands (0.7%) in 559 sporadic cases; however, no variants were detected in the other 1,388 probands with autosomal recessive or unknown family history. Among the 30 individuals possessing variants, marked variations were observed in the onset of HL as well as in the presence of progressive HL and tinnitus. Vestibular symptoms, which had been rarely reported, were present in 7 out of 30 (23%) of the affected individuals. The most prevalent audiometric configuration was low-frequency type; however, some individuals had high-frequency HL. Haplotype analysis in three mutations (p.A716T, p.K836T, and p.E864K) suggested that the mutations occurred at these mutation hot spots. The present study provided new insights into the audiovestibular phenotypes in patients with WFS1 mutations.

Indexed as

AdolescentAdultAgedAge of OnsetAsian PeopleAudiometryChildDNA Mutational AnalysisFemaleHaplotypesHearing Loss, SensorineuralHigh-Throughput Nucleotide SequencingHumansMaleMembrane ProteinsMiddle AgedMembrane Proteinswolframin protein

Identifiers

PMID29529044
PMCPMC5846739
OpenAlexW2791749967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.